BARBERIO, BRIGIDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.980
EU - Europa 292
AS - Asia 167
AF - Africa 5
Totale 2.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.975
IT - Italia 149
CN - Cina 91
FI - Finlandia 51
VN - Vietnam 34
GB - Regno Unito 32
DE - Germania 20
IN - India 17
IE - Irlanda 13
SE - Svezia 8
CA - Canada 5
HK - Hong Kong 5
IR - Iran 5
PH - Filippine 5
FR - Francia 4
EG - Egitto 3
ID - Indonesia 3
JP - Giappone 3
NL - Olanda 3
AT - Austria 2
CH - Svizzera 2
IQ - Iraq 2
LS - Lesotho 2
UA - Ucraina 2
BG - Bulgaria 1
DK - Danimarca 1
ES - Italia 1
IL - Israele 1
KR - Corea 1
NO - Norvegia 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 2.444
Salva come PNG Salva come JPEG
Città #
Fairfield 397
Chandler 210
Seattle 134
Woodbridge 134
Ashburn 133
Cambridge 127
Houston 121
San Diego 91
Wilmington 77
Medford 59
Princeton 59
Roxbury 50
Helsinki 48
Padova 47
Ann Arbor 46
Beijing 46
Des Moines 40
Dong Ket 30
Pune 17
Milan 16
London 10
Ogden 8
Dublin 7
Curtarolo 5
Menlo Park 5
Norwalk 5
Hong Kong 4
Manila 4
Prescot 4
Cagliari 3
Deiva Marina 3
Guangzhou 3
Hamilton 3
Hanoi 3
Hounslow 3
Kish 3
Lappeenranta 3
New York 3
San Martino Buon Albergo 3
Verona 3
Alexandria 2
Aversa 2
Baghdad 2
Boardman 2
Brendola 2
Calenzano 2
Campi Bisenzio 2
Cernusco sul Naviglio 2
Chicago 2
Chiswick 2
Daita 2
Genoa 2
Jacurso 2
Kharkiv 2
Las Vegas 2
Liverpool 2
Los Angeles 2
Maseru 2
Padang 2
Palermo 2
Ponte Lambro 2
San Jose 2
Shanghai 2
Venice 2
Vienna 2
Vigodarzere 2
Zurich 2
Albuquerque 1
Amsterdam 1
Andover 1
Borås 1
Broomfield 1
Cairo 1
Casier 1
Central 1
Cigognola 1
Crespino 1
Düsseldorf 1
Edinburgh 1
Enschede 1
Falkenstein 1
Fuzhou 1
Gava 1
Haikou 1
Hamburg 1
Hebei 1
Hendon 1
Ho Chi Minh City 1
Iligan City 1
Islington 1
Jinan 1
Kashan 1
Kilburn 1
Lanzhou 1
Leawood 1
Manchester 1
Motta di Livenza 1
Nanchang 1
Paris 1
Redmond 1
Totale 2.054
Salva come PNG Salva come JPEG
Nome #
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic Esophagitis 99
REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY 89
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab 84
Fecal microbiota transplantation for norovirus infection: a clinical and microbiological success. 72
Gastrointestinal: An unusual rectal finding in a patient with ulcerative colitis 71
Updates in the field of non-esophageal gastroesophageal reflux disorder 68
Advancements in the use of manometry and impedance testing for esophageal functional disorders 68
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital 67
A survey on nutritional knowledge in coeliac disease compared to inflammatory bowel diseases patients and healthy subjects 66
Vonoprazan may provide better results than ppis in helicobacter pylori eradication and beyond – is it time for a change? 63
Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak 60
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study 59
Novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-Tnf: Neutrophil-To-lymphocyte ratio and platelet-To-lymphocyte ratio 56
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 55
Perception of the COVID-19 pandemic among patients with inflammatory bowel disease in the time of telemedicine: cross-sectional questionnaire study 54
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach 53
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis 52
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator 51
Inflammatory Bowel Disease and Sleep Disturbance: As Usual, Quality Matters 50
Medical and gastroenterological education during the COVID-19 outbreak 49
Prevention Strategies for Esophageal Cancer-An Expert Review 49
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak 48
The Lyon Consensus: Does it differ from the previous ones? 48
Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria 47
The risk of malignancies in celiac disease—A literature review 45
Vonoprazan fumarate for the treatment of gastric ulcers: A short review on emerging data 44
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 43
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 42
Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario 40
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study 38
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study 34
Reorganization of the functional gastrointestinal disorders unit during the SARS-CoV-2 outbreak - Practical Recommendations 33
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients 33
Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis 33
Eosinophilic esophagitis and biologics 32
The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem? 32
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders 31
Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation 31
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases 30
A Peculiar Cutaneous Manifestation in a Patient With Crohn's Disease 29
Response to Khalaf et al 26
Hospitalisation for drug infusion did not increase levels of anxiety and the risk of disease relapse in patients with inflammatory bowel disease during covid-19 outbreak 25
Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases 24
Eosinophilic Esophagitis and Achalasia: Are We Putting All the Pieces Together? 24
Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis 23
Bariatric Surgery and Esophageal Function: An Eternal Impasse? 21
An "Old" Esophagus 20
Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta-analysis 20
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis 19
Reply to letter to the editor: Nlr and plr as novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-Tnf 19
Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study 18
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials: Future Treatments for EGIDS: Systematic Review 17
Eosinophilic esophagitis: from pathophysiology to management 17
Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis 17
Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis 17
Modern diagnosis of early esophageal cancer: From blood biomarkers to advanced endoscopy and artificial intelligence 16
Derivation and validation of a novel method to subgroup patients with functional dyspepsia: beyond upper gastrointestinal symptoms 15
Myocarditis and inflammatory bowel diseases: A single-center experience and a systematic literature review 15
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment? 14
Systematic Review: esophageal motility patterns in patients with eosinophilic esophagitis 14
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting 13
Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome 13
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey 12
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility 11
MICRO-RNAs TISSUTALI COME BIOMARCATORI DI DIAGNOSI PRECOCE E MONITORAGGIO IN PAZIENTI CON CANCRO DEL COLONRETTO ASSOCIATO A MALATTIA INFIAMMATORIA CRONICA INTESTINALE 10
Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis 8
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis 7
Non-hepatic solid organ transplant in patients with inflammatory bowel disease: an ECCO CONFER Multicentre Case Series 6
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicenter Case Series 5
Systematic review with meta-analysis: artificial intelligence in the diagnosis of oesophageal diseases 4
Totale 2.518
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.173
article - articoli 16.146
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.319
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202087 0 0 0 0 0 1 4 7 10 30 31 4
2020/2021596 29 2 82 2 5 110 110 37 65 39 14 101
2021/2022927 38 56 66 43 115 105 86 44 106 46 42 180
2022/2023514 106 11 24 69 69 59 6 34 57 13 47 19
2023/2024394 41 53 53 41 38 45 45 36 29 13 0 0
Totale 2.518